Solaris Resources Inc. (CVE:SLS – Get Free Report)’s stock price was down 2.7% during mid-day trading on Thursday . The company traded as low as C$5.95 and last traded at C$6.15. Approximately 53,313 shares traded hands during trading, a decline of 60% from the average daily volume of 132,199 shares. The stock had previously closed at C$6.32.
Solaris Resources Trading Down 2.7 %
The company’s fifty day moving average price is C$6.15 and its 200 day moving average price is C$6.15.
About Solaris Resources
SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.
See Also
- Five stocks we like better than Solaris Resources
- Upcoming IPO Stock Lockup Period, Explained
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Overbought Stocks Explained: Should You Trade Them?
- Nebius Group: The Rising Star in AI Infrastructure
- Russell 2000 Index, How Investors Use it For Profitable Trading
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with MarketBeat.com's FREE daily email newsletter.
